HHS: Harte Hanks Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Harte Hanks Inc (HHS).
$37.54M Market Cap.
HHS Market Cap. (MRY)
HHS Shares Outstanding (MRY)
HHS Assets (MRY)
Total Assets
$101.78M
Total Liabilities
$80.09M
Total Investments
$0
HHS Income (MRY)
Revenue
$185.24M
Net Income
-$30.30M
Operating Expense
$126.50M
HHS Cash Flow (MRY)
CF Operations
-$2.99M
CF Investing
-$3.74M
CF Financing
-$419.00K
HHS Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $101,782,000 (-17.09%) | $122,757,000 (2.31%) | $119,984,000 (11.24%) | $107,861,000 (-9.74%) |
Assets Current | $53,614,000 (-17.79%) | $65,213,000 (-1.66%) | $66,311,000 (-12.03%) | $75,375,000 (-12.60%) |
Assets Non-Current | $48,168,000 (-16.29%) | $57,544,000 (7.21%) | $53,673,000 (65.22%) | $32,486,000 (-2.33%) |
Goodwill & Intangible Assets | $858,000 (-81.92%) | $4,746,000 (-20.07%) | $5,938,000 (0%) | $0 (0%) |
Shareholders Equity | $21,689,000 (9.23%) | $19,857,000 (5.58%) | $18,808,000 (176.10%) | -$24,715,000 (53.48%) |
Property Plant & Equipment Net | $31,416,000 (-8.33%) | $34,272,000 (15.43%) | $29,692,000 (-0.66%) | $29,889,000 (-2.41%) |
Cash & Equivalents | $9,934,000 (-45.91%) | $18,364,000 (77.19%) | $10,364,000 (-31.51%) | $15,133,000 (-54.91%) |
Accumulated Other Comprehensive Income | -$13,597,000 (69.16%) | -$44,090,000 (8.72%) | -$48,302,000 (9.42%) | -$53,328,000 (18.72%) |
Deferred Revenue | $1,589,000 (-50.27%) | $3,195,000 (-30.39%) | $4,590,000 (16.44%) | $3,942,000 (-15.43%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $39,863,000 (-5.65%) | $42,248,000 (-11.80%) | $47,902,000 (-2.61%) | $49,185,000 (18.42%) |
Trade & Non-Trade Payables | $21,832,000 (-5.80%) | $23,176,000 (3.16%) | $22,465,000 (39.26%) | $16,132,000 (-0.99%) |
Accumulated Retained Earnings (Deficit) | $814,623,000 (-3.59%) | $844,920,000 (-0.19%) | $846,490,000 (4.36%) | $811,094,000 (1.88%) |
Tax Assets | $16,115,000 (-15.30%) | $19,026,000 (-7.50%) | $20,568,000 (175.86%) | $7,456,000 (0.92%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $24,596,000 (-13.72%) | $28,506,000 (27.70%) | $22,322,000 (-27.45%) | $30,768,000 (-44.12%) |
Debt Current | $3,736,000 (-22.41%) | $4,815,000 (-16.22%) | $5,747,000 (-12.30%) | $6,553,000 (-43.46%) |
Debt Non-Current | $20,860,000 (-11.95%) | $23,691,000 (42.93%) | $16,575,000 (-31.55%) | $24,215,000 (-44.29%) |
Total Liabilities | $80,093,000 (-22.16%) | $102,900,000 (1.70%) | $101,176,000 (-17.64%) | $122,853,000 (-24.58%) |
Liabilities Current | $35,137,000 (-26.97%) | $48,111,000 (10.43%) | $43,566,000 (2.65%) | $42,442,000 (-10.07%) |
Liabilities Non-Current | $44,956,000 (-17.95%) | $54,789,000 (-4.90%) | $57,610,000 (-28.36%) | $80,411,000 (-30.50%) |
HHS Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $185,242,000 (-3.26%) | $191,492,000 (-7.17%) | $206,278,000 (6.00%) | $194,596,000 (10.00%) |
Cost of Revenue | $56,644,000 (-4.91%) | $59,568,000 (-3.81%) | $61,930,000 (23.21%) | $50,264,000 (1.98%) |
Selling General & Administrative Expense | $116,550,000 (-1.76%) | $118,641,000 (-6.22%) | $126,513,000 (-0.99%) | $127,775,000 (2.06%) |
Research & Development Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Expenses | $126,505,000 (-1.60%) | $128,565,000 (-0.52%) | $129,241,000 (-5.45%) | $136,693,000 (-1.08%) |
Interest Expense | $187,000 (238.52%) | -$135,000 (-130.82%) | $438,000 (-51.50%) | $903,000 (-22.42%) |
Income Tax Expense | -$7,637,000 (-2088.25%) | -$349,000 (98.00%) | -$17,463,000 (-1455.82%) | $1,288,000 (107.75%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$30,297,000 (-1829.75%) | -$1,570,000 (-104.27%) | $36,776,000 (145.65%) | $14,971,000 (983.77%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$30,297,000 (-1829.75%) | -$1,570,000 (-104.27%) | $36,776,000 (145.65%) | $14,971,000 (983.77%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $1,380,000 (-41.38%) | $2,354,000 (374.60%) |
Net Income Common Stock | -$30,297,000 (-1829.75%) | -$1,570,000 (-104.44%) | $35,396,000 (180.54%) | $12,617,000 (676.12%) |
Weighted Average Shares | $7,293,000 (-0.23%) | $7,310,000 (2.94%) | $7,101,000 (4.40%) | $6,802,000 (5.15%) |
Weighted Average Shares Diluted | $7,293,000 (-0.23%) | $7,310,000 (-1.97%) | $7,457,000 (3.44%) | $7,209,000 (11.44%) |
Earning Before Interest & Taxes (EBIT) | -$37,747,000 (-1737.73%) | -$2,054,000 (-110.40%) | $19,751,000 (15.09%) | $17,162,000 (200.10%) |
Gross Profit | $128,598,000 (-2.52%) | $131,924,000 (-8.61%) | $144,348,000 (0.01%) | $144,332,000 (13.10%) |
Operating Income | $2,093,000 (-37.69%) | $3,359,000 (-77.77%) | $15,107,000 (97.76%) | $7,639,000 (172.23%) |
HHS Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$3,744,000 (-62.15%) | -$2,309,000 (79.91%) | -$11,493,000 (-296.31%) | -$2,900,000 (-274.19%) |
Net Cash Flow from Financing | -$419,000 (86.97%) | -$3,216,000 (79.67%) | -$15,820,000 (-17.95%) | -$13,413,000 (-283.41%) |
Net Cash Flow from Operations | -$2,987,000 (-128.51%) | $10,477,000 (-63.61%) | $28,792,000 (1733.13%) | -$1,763,000 (77.51%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$8,930,000 (-219.07%) | $7,500,000 (298.99%) | -$3,769,000 (79.55%) | -$18,429,000 (-3190.89%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $500,000 (108.70%) | -$5,750,000 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$3,744,000 (-33.29%) | -$2,809,000 (51.09%) | -$5,743,000 (-98.03%) | -$2,900,000 (-274.19%) |
Issuance (Repayment) of Debt Securities | -$124,000 (22.50%) | -$160,000 (96.92%) | -$5,194,000 (57.86%) | -$12,327,000 (-254.32%) |
Issuance (Purchase) of Equity Shares | -$295,000 (90.20%) | -$3,011,000 (-542.00%) | -$469,000 (-61.17%) | -$291,000 (-1222.73%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | -$1,780,000 (-169.86%) | $2,548,000 (148.55%) | -$5,248,000 (-1386.69%) | -$353,000 (-147.57%) |
Share Based Compensation | $1,931,000 (36.18%) | $1,418,000 (-39.79%) | $2,355,000 (60.31%) | $1,469,000 (92.28%) |
Depreciation Amortization & Accretion | $4,385,000 (3.49%) | $4,237,000 (55.32%) | $2,728,000 (6.60%) | $2,559,000 (-29.21%) |
HHS Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 69.40% (0.73%) | 68.90% (-1.57%) | 70.00% (-5.66%) | 74.20% (2.91%) |
Profit Margin | -16.40% (-1950.00%) | -0.80% (-104.65%) | 17.20% (164.62%) | 6.50% (641.67%) |
EBITDA Margin | -18.00% (-1736.36%) | 1.10% (-89.91%) | 10.90% (7.92%) | 10.10% (232.89%) |
Return on Average Equity (ROAE) | -145.50% (-1789.61%) | -7.70% (98.25%) | -438.80% (-1293.02%) | -31.50% (-800.00%) |
Return on Average Assets (ROAA) | -28.00% (-1900.00%) | -1.40% (-104.52%) | 31.00% (176.79%) | 11.20% (689.47%) |
Return on Sales (ROS) | -20.40% (-1754.55%) | -1.10% (-111.46%) | 9.60% (9.09%) | 8.80% (190.72%) |
Return on Invested Capital (ROIC) | -45.00% (-1566.67%) | -2.70% (-111.39%) | 23.70% (19.10%) | 19.90% (195.67%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -1.24 (96.16%) | -32.33 (-1477.63%) | 2.35 (-42.87%) | 4.11 (150.79%) |
Price to Sales Ratio (P/S) | 0.2 (-21.62%) | 0.26 (-35.57%) | 0.4 (51.13%) | 0.27 (163.37%) |
Price to Book Ratio (P/B) | 1.73 (-29.86%) | 2.47 (-44.98%) | 4.49 (309.14%) | -2.15 (-532.74%) |
Debt to Equity Ratio (D/E) | 3.69 (-28.73%) | 5.18 (-3.66%) | 5.38 (208.21%) | -4.97 (-62.13%) |
Earnings Per Share (EPS) | -4.15 (-1876.19%) | -0.21 (-104.22%) | 4.98 (169.19%) | 1.85 (644.12%) |
Sales Per Share (SPS) | 25.4 (-3.04%) | 26.2 (-9.82%) | 29.05 (1.54%) | 28.61 (4.62%) |
Free Cash Flow Per Share (FCFPS) | -0.92 (-187.99%) | 1.05 (-67.68%) | 3.25 (573.18%) | -0.69 (48.50%) |
Book Value Per Share (BVPS) | 2.97 (9.50%) | 2.72 (2.53%) | 2.65 (172.91%) | -3.63 (55.76%) |
Tangible Assets Book Value Per Share (TABVPS) | 13.84 (-14.28%) | 16.14 (0.52%) | 16.06 (1.29%) | 15.86 (-14.16%) |
Enterprise Value Over EBIT (EV/EBIT) | -2 (92.59%) | -27 (-640.00%) | 5 (25.00%) | 4 (300.00%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -1.7 (-106.80%) | 25.06 (485.29%) | 4.28 (17.96%) | 3.63 (258.65%) |
Asset Turnover | 1.71 (3.45%) | 1.65 (-8.52%) | 1.81 (4.75%) | 1.73 (14.08%) |
Current Ratio | 1.53 (12.62%) | 1.35 (-10.97%) | 1.52 (-14.30%) | 1.78 (-2.79%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$6,731,000 (-187.78%) | $7,668,000 (-66.73%) | $23,049,000 (594.30%) | -$4,663,000 (45.87%) |
Enterprise Value (EV) | $56,825,262 (3.87%) | $54,709,772 (-43.16%) | $96,249,806 (34.44%) | $71,590,694 (131.27%) |
Earnings Before Tax (EBT) | -$37,934,000 (-1876.76%) | -$1,919,000 (-109.94%) | $19,313,000 (18.78%) | $16,259,000 (188.80%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$33,362,000 (-1628.26%) | $2,183,000 (-90.29%) | $22,479,000 (13.99%) | $19,721,000 (245.76%) |
Invested Capital | $80,449,000 (0.51%) | $80,042,000 (-2.91%) | $82,438,000 (1.71%) | $81,054,000 (-13.59%) |
Working Capital | $18,477,000 (8.04%) | $17,102,000 (-24.81%) | $22,745,000 (-30.94%) | $32,933,000 (-15.66%) |
Tangible Asset Value | $100,924,000 (-14.48%) | $118,011,000 (3.48%) | $114,046,000 (5.73%) | $107,861,000 (-9.74%) |
Market Capitalization | $37,538,262 (-23.39%) | $48,998,772 (-41.93%) | $84,378,806 (59.15%) | $53,018,694 (194.37%) |
Average Equity | $20,827,000 (1.75%) | $20,469,000 (353.78%) | -$8,065,750 (79.85%) | -$40,021,000 (18.21%) |
Average Assets | $108,271,500 (-6.48%) | $115,778,000 (1.47%) | $114,097,750 (1.22%) | $112,721,000 (-3.56%) |
Invested Capital Average | $83,924,750 (8.98%) | $77,007,500 (-7.77%) | $83,494,750 (-3.19%) | $86,246,250 (4.43%) |
Shares | 7,288,983 (1.01%) | 7,216,314 (-0.02%) | 7,218,033 (3.47%) | 6,976,144 (6.52%) |
